PULMONX CORPORATION Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
PULMONX CORPORATION (LUNG) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$120.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-04
- PULMONX CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$120.00K, a 127.65% decline year-over-year.
- PULMONX CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$191.00K, a 314.61% decline year-over-year.
- PULMONX CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $122.00K.
- PULMONX CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was -$398.00K, a 170.94% decline year-over-year.
- PULMONX CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $247.00K.
- PULMONX CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$527.00K, a 149.48% decline from fiscal 2023.
- PULMONX CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $1.06M.
- PULMONX CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$137.00K, a 607.41% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$120.00K 10-Q · filed 2026-08-04 | -$311.00K 10-Q · filed 2026-08-04 | -$189.00K derived: sum of 3 quarters · filed 2026-08-04 | -$587.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$191.00K 10-Q · filed 2026-05-04 | -$69.00K derived: sum of 2 quarters · filed 2026-05-04 | -$467.00K derived: sum of 3 quarters · filed 2026-05-04 | -$33.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$276.00K derived: sum of 2 quarters · filed 2026-03-10 | $158.00K derived: sum of 3 quarters · filed 2026-08-04 | $247.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | -$398.00K 10-Q · filed 2025-11-12 | $36.00K derived: sum of 2 quarters · filed 2026-08-04 | $125.00K 10-Q · filed 2025-11-12 | -$296.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $434.00K 10-Q · filed 2026-08-04 | $523.00K 10-Q · filed 2026-08-04 | $102.00K derived: sum of 3 quarters · filed 2026-08-04 | $663.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $89.00K 10-Q · filed 2026-05-04 | -$332.00K derived: sum of 2 quarters · filed 2026-05-04 | $229.00K derived: sum of 3 quarters · filed 2026-05-04 | $239.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$421.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $140.00K derived: sum of 2 quarters · filed 2026-03-10 | $150.00K derived: sum of 3 quarters · filed 2026-03-10 | -$527.00K 10-K · filed 2026-03-10 |
| 2024-09-30 | $561.00K 10-Q · filed 2025-11-12 | $571.00K derived: sum of 2 quarters · filed 2025-11-12 | -$106.00K 10-Q · filed 2025-11-12 | $590.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $10.00K 10-Q · filed 2025-08-01 | -$667.00K 10-Q · filed 2025-08-01 | $29.00K derived: sum of 3 quarters · filed 2025-08-01 | $17.00K derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | -$677.00K 10-Q · filed 2025-05-02 | $19.00K derived: sum of 2 quarters · filed 2025-05-02 | $7.00K derived: sum of 3 quarters · filed 2025-05-02 | $143.00K derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $696.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $684.00K derived: sum of 2 quarters · filed 2025-02-25 | $820.00K derived: sum of 3 quarters · filed 2025-02-25 | $1.06M 10-K · filed 2025-02-25 |
| 2023-09-30 | -$12.00K 10-Q · filed 2024-11-01 | $124.00K derived: sum of 2 quarters · filed 2024-11-01 | $369.00K 10-Q · filed 2024-11-01 | $547.00K derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $136.00K 10-Q · filed 2024-08-02 | $381.00K 10-Q · filed 2024-08-02 | $559.00K derived: sum of 3 quarters · filed 2024-08-02 | $599.00K derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $245.00K 10-Q · filed 2024-05-03 | $423.00K derived: sum of 2 quarters · filed 2024-05-03 | $463.00K derived: sum of 3 quarters · filed 2024-05-03 | $377.00K derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $218.00K derived: sum of 2 quarters · filed 2024-02-27 | $132.00K derived: sum of 3 quarters · filed 2024-02-27 | -$137.00K 10-K · filed 2024-02-27 |
| 2022-09-30 | $40.00K 10-Q · filed 2023-11-03 | -$46.00K derived: sum of 2 quarters · filed 2023-11-03 | -$315.00K 10-Q · filed 2023-11-03 | -$147.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | -$86.00K 10-Q · filed 2023-08-04 | -$355.00K 10-Q · filed 2023-08-04 | -$187.00K derived: sum of 3 quarters · filed 2023-08-04 | -$122.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | -$269.00K 10-Q · filed 2023-05-08 | -$101.00K derived: sum of 2 quarters · filed 2023-05-08 | -$36.00K derived: sum of 3 quarters · filed 2023-05-08 | $33.00K derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $233.00K derived: sum of 2 quarters · filed 2023-03-01 | $302.00K derived: sum of 3 quarters · filed 2023-03-01 | $27.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | $65.00K 10-Q · filed 2022-11-08 | $134.00K derived: sum of 2 quarters · filed 2022-11-08 | -$141.00K 10-Q · filed 2022-11-08 | -$104.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $69.00K 10-Q · filed 2022-08-08 | -$206.00K 10-Q · filed 2022-08-08 | -$169.00K derived: sum of 3 quarters · filed 2022-08-08 | -$136.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$275.00K 10-Q · filed 2022-05-09 | -$238.00K derived: sum of 2 quarters · filed 2022-05-09 | -$205.00K derived: sum of 3 quarters · filed 2022-05-09 | -$240.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $70.00K derived: sum of 2 quarters · filed 2022-03-01 | $35.00K derived: sum of 3 quarters · filed 2022-03-01 | $312.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $33.00K 10-Q · filed 2021-11-09 | -$2.00K derived: sum of 2 quarters · filed 2021-11-09 | $275.00K 10-Q · filed 2021-11-09 | $181.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$35.00K 10-Q · filed 2021-08-10 | $242.00K 10-Q · filed 2021-08-10 | $148.00K derived: sum of 3 quarters · filed 2021-08-10 | $226.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $277.00K 10-Q · filed 2021-05-12 | $183.00K derived: sum of 2 quarters · filed 2021-05-12 | $261.00K derived: sum of 3 quarters · filed 2021-05-12 | |
| 2019-12-31 | -$94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$16.00K derived: sum of 2 quarters · filed 2021-03-15 | $40.00K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $78.00K 10-Q · filed 2020-11-13 | $134.00K 10-Q · filed 2020-11-13 | ||
| 2018-12-31 | $126.00K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |